jueves, 18 de septiembre de 2025
Editorial p801 NINDS at the forefront of epilepsy research for 75 years The Lancet Neurology + +...
Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00269-8/abstract?dgcid=raven_jbs_etoc_feature_laneur
Editorial
p801
NINDS at the forefront of epilepsy research for 75 years
The Lancet Neurology
https://www.thelancet.com/journals/laneur/issue/vol24no10/PIIS1474-4422(25)X0010-7
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario